Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity

NCT07227051 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2026-04-13

No results posted yet for this study

Summary

The purpose of this research study is to learn how to best provide weekly feedback on individual progress toward intervention goals during a weight loss program.

Conditions

  • Obesity & Overweight
  • Obesity (Disorder)

Interventions

BEHAVIORAL

Feedback on Calorie Goal Attainment

Feedback composed by a study interventionist that focuses on the participant's progress toward meeting their caloric intake goal.

BEHAVIORAL

Feedback on Dietary Quality

Feedback composed by a study interventionist that provides comments on specific dietary choices that may impact weight loss success.

BEHAVIORAL

Feedback on Physical Activity Goal Attainment

Feedback composed by a study interventionist that focuses on the participant's progress toward meeting their physical activity goal.

BEHAVIORAL

Goal Setting Prompt

An open-text goal setting prompt, composed by the study interventionist, that encourages the participant to set a behavioral goal for the following week.

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH
  • University of Virginia

    collaborator OTHER
  • University of Florida

    collaborator OTHER
  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Kathryn M. Ross, Ph.D., M.P.H. · Aurora Research Institute LLC

  • Rebecca A. Krukowski, Ph.D. · University of Virginia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-26
Primary Completion
2028-02-28
Completion
2028-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07227051 on ClinicalTrials.gov